SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-066641
Filing Date
2024-08-08
Accepted
2024-08-08 16:25:58
Documents
15
Period of Report
2024-08-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0210870-8k_optimize.htm   iXBRL 8-K 25164
2 PRESS RELEASE, DATED AUGUST 8, 2024 ea021087001ex99-1_optimize.htm EX-99.1 131309
3 GRAPHIC ex99-1_001.jpg GRAPHIC 12008
  Complete submission text file 0001213900-24-066641.txt   361054

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE oprx-20240808.xsd EX-101.SCH 3021
5 XBRL LABEL FILE oprx-20240808_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE oprx-20240808_pre.xml EX-101.PRE 22363
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0210870-8k_optimize_htm.xml XML 3671
Mailing Address 260 CHARLES STREET SUITE 302 WALTHAM MA 02453
Business Address 260 CHARLES STREET SUITE 302 WALTHAM MA 02453 248-651-6558
OptimizeRx Corp (Filer) CIK: 0001448431 (see all company filings)

IRS No.: 261265381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38543 | Film No.: 241188854
SIC: 7389 Services-Business Services, NEC
(CF Office: 07 Trade & Services)